BBM — Blueberries Medical Income Statement
0.000.00%
Last trade - 00:00
- CA$5.99m
- CA$6.99m
- CA$0.24m
2018 March 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.066 | 0.139 | 0.235 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.062 | -0.245 | -0.018 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.015 | 10.8 | 4.19 | 5.19 | 1.78 |
Operating Profit | -0.015 | -10.8 | -4.12 | -5.05 | -1.55 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.015 | -10.8 | -4.94 | -5.15 | -1.47 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.015 | -10.8 | -4.94 | -5.15 | -1.47 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.015 | -10.8 | -4.94 | -5.15 | -1.47 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.015 | -10.8 | -4.94 | -5.15 | -1.47 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.219 | -0.062 | -0.04 | -0.012 | -0.01 |
Dividends per Share |